Literature DB >> 11458708

Cardiac vagal chemosensory afferents. Function in pathophysiological states.

H D Schultz1.   

Abstract

Stimulation of cardiac vagal afferent endings evokes reflex hypotension and bradycardia, also known as a Bezold-Jarisch effect. The physiological importance of this reflex pathway remains uncertain today, but it is increasingly apparent that cardiac vagal afferents can play an important role in modulating cardiovascular control in pathophysiological states, particularly myocardial ischemia. The afferent endings that compose this vagal input are functionally diverse. Ventricular endings exist that are stimulated by wall motion. However, cardiac chemosensitive endings, stimulated by a variety of metabolically active substances known to be produced by the stressed myocardium (e.g., bradykinin, prostaglandins, reactive oxygen species), play a major role in mediating reflex adjustments during myocardial ischemia. Data are presented highlighting the importance of arachidonic acid metabolites and oxygen radicals in activating cardiac vagal endings during myocardial ischemia and reperfusion, and their role in modulating cardiac afferent sensitivity in the disease states of heart failure and insulin-dependent diabetes.

Entities:  

Mesh:

Year:  2001        PMID: 11458708

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  15 in total

Review 1.  Major Autonomic Neuroregulatory Pathways Underlying Short- and Long-Term Control of Cardiovascular Function.

Authors:  Ibrahim M Salman
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

2.  NTS adenosine A2a receptors inhibit the cardiopulmonary chemoreflex control of regional sympathetic outputs via a GABAergic mechanism.

Authors:  Zeljka Minic; Donal S O'Leary; Tadeusz J Scislo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-04-24       Impact factor: 4.733

3.  Activation of NTS A(1) adenosine receptors inhibits regional sympathetic responses evoked by activation of cardiopulmonary chemoreflex.

Authors:  Tomoko K Ichinose; Zeljka Minic; Cailian Li; Donal S O'Leary; Tadeusz J Scislo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-07-18       Impact factor: 3.619

Review 4.  Central nervous system circuits modified in heart failure: pathophysiology and therapeutic implications.

Authors:  Bernardo Sousa-Pinto; Manuel J Ferreira-Pinto; Mário Santos; Adelino F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

5.  Characterization of upper thoracic spinal neurons receiving noxious cardiac and/or somatic inputs in diabetic rats.

Authors:  Marie Louise M Ghorbani; Chao Qin; Mingyuan Wu; Jay P Farber; Majid Sheykhzade; Bjarne Fjalland; Niels C B Nyborg; Robert D Foreman
Journal:  Auton Neurosci       Date:  2011-09-08       Impact factor: 3.145

6.  Nucleus tractus solitarii A(2a) adenosine receptors inhibit cardiopulmonary chemoreflex control of sympathetic outputs.

Authors:  Zeljka Minic; Donal S O'Leary; Tadeusz J Scislo
Journal:  Auton Neurosci       Date:  2013-10-25       Impact factor: 3.145

7.  Mechano- and chemosensitivity of rat nodose neurones--selective excitatory effects of prostacyclin.

Authors:  Vladislav Snitsarev; Carol A Whiteis; Mark W Chapleau; François M Abboud
Journal:  J Physiol       Date:  2007-05-03       Impact factor: 5.182

8.  Roles of arterial baroreceptor reflex during bezold-jarisch reflex.

Authors:  Koji Kashihara
Journal:  Curr Cardiol Rev       Date:  2009-11

9.  The volume-regulated anion channel (LRRC8) in nodose neurons is sensitive to acidic pH.

Authors:  Runping Wang; Yongjun Lu; Susheel Gunasekar; Yanhui Zhang; Christopher J Benson; Mark W Chapleau; Rajan Sah; François M Abboud
Journal:  JCI Insight       Date:  2017-03-09

Review 10.  Molecular and cellular neurocardiology: development, and cellular and molecular adaptations to heart disease.

Authors:  Beth A Habecker; Mark E Anderson; Susan J Birren; Keiichi Fukuda; Neil Herring; Donald B Hoover; Hideaki Kanazawa; David J Paterson; Crystal M Ripplinger
Journal:  J Physiol       Date:  2016-06-17       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.